Journal profile · Medicine-Dermatology
Clinical Cosmetic and Investigational Dermatology
ISSN 1178-7015 · Dove Medical Press · NEW ZEALAND
Clinical Cosmetic and Investigational Dermatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.5; JCR Q2 (journal website); fully open access; APC about USD 3,940; median 78 days to acceptance (131 articles, last 24 months); acceptance rate 23% (journal website); 360 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Cosmetic and Investigational Dermatology is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dermatologic Treatments and Research, Dermatology and Skin Diseases and Acne and Rosacea Treatments and Effects, together about 29.3% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Dr Jeffrey M Weinberg Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care. Specific topics covered by the journal include: Normal and pathological processes in skin development and aging, their modification and treatment Basic research into histology of dermal structures Clinical insights and potential treatment options Patient satisfaction, preference, quality of life, compliance Development of new management options to optimize outcomes for target conditions The journal welcomes submissions on the following sections: Cosmetic Dermatology Dermatologic Surgery Dermatopathology Hair and Nails Medical Dermatology Clinical, Cosmetic and Investigational Dermatology will no longer consider Meta-analyses for publication. Updated 12 August 2026
From the journal's Aims & Scope
Research area (LetPub): Medicine-Dermatology
Editor-in-chief Jeffrey M WeinbergPublisher website
Editorial board by country: 10 in mainland China (about 12%); most named United States 26, Italy 18, Mainland China 10, Egypt 6, Canada 3 (82 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dermatologic Treatments and ResearchMedicine11%
- Dermatology and Skin DiseasesMedicine10%
- Acne and Rosacea Treatments and EffectsMedicine8.3%
- Skin Protection and AgingMedicine7.6%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology7.4%
- Facial Rejuvenation and Surgery TechniquesMedicine6.3%
- Hair Growth and DisordersMedicine5.8%
- melanin and skin pigmentationBiochemistry, Genetics and Molecular Biology5.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.5LetPub ·
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- 5-year impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher) 2025
- 1.09Publisher website ·
- SJR 2026-06
- 0.72LetPub ·
- SNIP 2026-06
- 1.09LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 881OpenAlex ·
- 2-year mean citedness
- 2.48OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 99.71%LetPub ·
Volume
- Articles per year
- 347LetPub ·
- Articles per year (publisher)
- 257Publisher website ·
- Downloads per year (publisher)
- 563,532Publisher website ·
Articles by year OpenAlex count · 2,624 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 369 | 369 | 71 |
| 2025 | 360 | 360 | 747 |
| 2024 | 321 | 321 | 1,783 |
| 2023 | 410 | 410 | 3,427 |
| 2022 | 317 | 317 | 3,591 |
| 2021 | 200 | 200 | 3,190 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
78 daysMedian, submission to acceptance · P25–P75 63 days – 100 days
- Acceptance to online
- median 14 days (131 articles)
- Submission to online
- median 95 days
- Sample
- 131 articles with submission and acceptance dates (812 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 23%Publisher website ·
- Desk decision
- 44 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,836 | — | — | |
| LetPub | USD 3,300 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websiteAI use, Publication ethics, Plagiarism, Trial registration / reporting guidelines
- AI use Automated Quantification of Shedding Hairs from Smartphone Photographs Using an AI Tool for Alopecia Monitoring
Zhang S, Zhang Y, Li X, Han P, Li X, Zhou C Clinical, Cosmetic and Investigational Dermatology 2026, 19:641573 Published Date: 15 September 2026
Source ↗Publisher website ·- Publication ethics
Member of and subscribes to the principles of the Committee on Publication Ethics (COPE) Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- Plagiarism
All submitted manuscripts are checked for plagiarism using Crossref Similarity Check (powered by iThenticate). Model summary
Please be aware that Dove Medical Press checks ALL submitted manuscripts for plagiarism. We use Crossref Similarity Check (powered by iThenticate).
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trials involving human subjects must be registered per Dove Medical Press requirements. Model summary
The section sets out the Dove Medical Press requirements for registration of any clinical trial involving human subjects.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- NEW ZEALAND
- Language
- English
- ISSN
- 1178-7015
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical Cosmetic and Investigational Dermatology
What CAS zone is Clinical Cosmetic and Investigational Dermatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Cosmetic and Investigational Dermatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Cosmetic and Investigational Dermatology?
The latest impact factor listed by LetPub is 2.5; CiteScore 4, h-index 80.
How long does peer review take at Clinical Cosmetic and Investigational Dermatology?
Based on the dates recorded on 131 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 63–100 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 23%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Clinical Cosmetic and Investigational Dermatology in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Clinical Cosmetic and Investigational Dermatology based?
Of the 82 board members whose country the journal's board page names, 10 (about 12%) are in mainland China; the countries named most often are United States (26), Italy (18) and Mainland China (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Cosmetic and Investigational Dermatology?
According to LetPub and DOAJ records, Clinical Cosmetic and Investigational Dermatology is indexed in SCIE, Scopus and DOAJ.
Is Clinical Cosmetic and Investigational Dermatology open access, and what is the APC?
Clinical Cosmetic and Investigational Dermatology is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .